Amarin Builds Sales Infrastructure For EU Vazkepa Launch

CHMP Positive Opinion At January Meeting

With an approval nod from the EMA’s scientific committee for its fish oil product Vazkepa, launch plans for the EU for this “multi-billion dollar” opportunity are on track, says Amarin CEO.

Amarin Corporation plc hopes to have its purified fish oil product Vazkepa (icosapent ethyl) on the market in the EU at a good price by the end of the year now that the European Medicines Agency’s medicines committee, the CHMP, has given it the go-ahead for approval.

On 29 January, the committee granted the product a positive opinion for reducing the risk of cardiovascular events in adult...